Zoetis Ownership

ZTS Stock  USD 176.74  1.04  0.59%   
Zoetis Inc retains a total of 451.16 Million outstanding shares. The majority of Zoetis outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Zoetis Inc to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Zoetis Inc. Please pay attention to any change in the institutional holdings of Zoetis Inc as this could imply that something significant has changed or is about to change at the company. Please note that on August 21, 2024, Representative Jared Moskowitz of US Congress acquired under $15k worth of Zoetis Inc's common stock.
 
Shares in Circulation  
First Issued
2011-03-31
Previous Quarter
456 M
Current Value
453.5 M
Avarage Shares Outstanding
485.4 M
Quarterly Volatility
14.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Zoetis in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Zoetis, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
At this time, Zoetis' Dividends Paid is comparatively stable compared to the past year. Dividend Yield is likely to gain to 0.01 in 2024, whereas Dividend Paid And Capex Coverage Ratio is likely to drop 1.54 in 2024. Net Income Applicable To Common Shares is likely to gain to about 2.6 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 389.2 M in 2024.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Zoetis Stock Ownership Analysis

About 96.0% of the company outstanding shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.45. Zoetis Inc recorded earning per share (EPS) of 5.36. The entity last dividend was issued on the 31st of October 2024. Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis Inc operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 12100 people. For more information please call Kristin Peck at 973 822 7000 or visit https://www.zoetis.com.
Besides selling stocks to institutional investors, Zoetis also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Zoetis' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Zoetis' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Zoetis Quarterly Liabilities And Stockholders Equity

14.36 Billion

Zoetis Insider Trades History

Less than 1% of Zoetis Inc are currently held by insiders. Unlike Zoetis' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Zoetis' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Zoetis' insider trades
 
Yuan Drop
 
Covid

Zoetis Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Zoetis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zoetis Inc backward and forwards among themselves. Zoetis' institutional investor refers to the entity that pools money to purchase Zoetis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Polen Capital2024-09-30
6.4 M
Northern Trust Corp2024-09-30
5.7 M
Norges Bank2024-06-30
M
Mizuho Securities Usa Inc2024-09-30
4.9 M
T. Rowe Price Associates, Inc.2024-06-30
4.8 M
Nuveen Asset Management, Llc2024-06-30
4.8 M
Goldman Sachs Group Inc2024-06-30
4.7 M
Bank Of New York Mellon Corp2024-06-30
4.7 M
Unisphere Establishment2024-09-30
4.5 M
Vanguard Group Inc2024-09-30
41.2 M
Blackrock Inc2024-06-30
36.8 M
Note, although Zoetis' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Zoetis Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zoetis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zoetis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zoetis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Zoetis' latest congressional trading

Congressional trading in companies like Zoetis Inc, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Zoetis by those in governmental positions are based on the same information available to the general public.
2024-08-21Representative Jared MoskowitzAcquired Under $15KVerify
2024-08-19Representative Jared MoskowitzAcquired Under $15KVerify
2024-08-06Representative Jared MoskowitzAcquired Under $15KVerify
2024-05-01Senator Markwayne MullinAcquired Under $15KVerify
2024-04-30Senator Markwayne MullinAcquired Under $15KVerify
2024-03-15Senator Shelley Moore CapitoAcquired $15K to $50KVerify
2024-03-14Senator Shelley Moore CapitoAcquired $15K to $50KVerify
2024-01-26Senator Markwayne MullinAcquired Under $15KVerify
2024-01-25Senator Markwayne MullinAcquired Under $15KVerify
2023-11-01Senator Markwayne MullinAcquired Under $15KVerify
2023-10-31Senator Markwayne MullinAcquired Under $15KVerify
2023-10-12Senator Markwayne MullinAcquired $15K to $50KVerify

Zoetis Outstanding Bonds

Zoetis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zoetis Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zoetis bonds can be classified according to their maturity, which is the date when Zoetis Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Zoetis Corporate Filings

F4
26th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F3
14th of November 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
4th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
26th of June 2024
Other Reports
ViewVerify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Zoetis Stock Analysis

When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.